The Scientist

» pharmaceuticals and culture

Most Recent

image: Daraprim Discounts Offered

Daraprim Discounts Offered

By | November 26, 2015

Turing Pharmaceuticals will soon offer discounts to hospitals for its toxoplasmosis-fighting drug, the company announced, but some say the proposed price reductions are not enough.

0 Comments

image: Agar Shortage Limits Lab Supplies

Agar Shortage Limits Lab Supplies

By | November 24, 2015

One large provider says the shortfall should clear up by early 2016.

1 Comment

image: Pfizer and Allergan to Merge

Pfizer and Allergan to Merge

By | November 23, 2015

The two drugmakers will join forces in a $160 billion deal—if it’s given the regulatory green light.

0 Comments

image: Following the Funding

Following the Funding

By | November 4, 2015

Researchers use network theory to estimate the importance of relationships among researchers and institutions in attracting grant money.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | November 1, 2015

The Psychology of Overeating, The Hidden Half of Nature, The Death of Cancer, and The Secret of Our Success

0 Comments

image: 2015 Life Sciences Salary Survey

2015 Life Sciences Salary Survey

By and | November 1, 2015

This year’s survey highlights dramatic regional, sector, and gender variations.

13 Comments

image: Daraprim Alternative

Daraprim Alternative

By | October 22, 2015

A specialty pharmaceuticals company announces plans to produce a toxoplasmosis drug containing the same active ingredient as the pill at the center of an ongoing drug-pricing controversy.

1 Comment

image: Scientists Skip Cell Line Validation

Scientists Skip Cell Line Validation

By | October 12, 2015

Despite known problems with contamination and mislabeled cell lines, most researchers continue to operate without authenticating cells’ identity.

2 Comments

image: Debating the Value of Anonymity

Debating the Value of Anonymity

By | October 5, 2015

PubPeer responds to criticism that anonymous post-publication peer review threatens the scientific process.

1 Comment

image: Teva Buys Mexican Pharma Firm

Teva Buys Mexican Pharma Firm

By | October 5, 2015

The Israeli drugmaker is purchasing the pharmaceutical company Rimsa for $2.3 billion.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Can Plants Learn to Associate Stimuli with Reward?
  4. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

Business Birmingham